Abstract
In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity of current clinical trial endpoints, we highlight the major areas of debate and provide alternative viewpoints that have implications for trial design and interpretation, as well as clinical practice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3205-3211 |
| Number of pages | 7 |
| Journal | Blood |
| Volume | 118 |
| Issue number | 12 |
| DOIs | |
| State | Published - Sep 22 2011 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology
Fingerprint
Dive into the research topics of 'Approach to the treatment of multiple myeloma: A clash of philosophies'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS